Free Trial
→ Midnight trade alert: After-hours spike incoming??? (From Timothy Sykes) (Ad) Buy PGNY Stock  Free PGNY Stock Alerts

Progyny (PGNY) Financials

Progyny logo
$21.86 +0.52 (+2.44%)
Closing price 05/30/2025 04:00 PM Eastern
Extended Trading
$21.46 -0.40 (-1.83%)
As of 05/30/2025 07:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Progyny

Annual Income Statements for Progyny

This table shows Progyny's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Net Income / (Loss) Attributable to Common Shareholders		 54 62 30 66 46 -8.57 -5.54 -26
Consolidated Net Income / (Loss)		 54 62 30 66 46 -8.57 0.66 -12
Net Income / (Loss) Continuing Operations		 54 62 30 66 46 -8.57 -5.12 -12
Total Pre-Tax Income 		83 71 24 32 8.68 -8.56 -6.89 -12
Total Operating Income		 67 62 23 32 8.35 9.68 -3.45 -11
Total Gross Profit		 253 239 167 112 70 46 19 7.40
Total Revenue		 1,167 1,089 787 501 345 230 105 49
Operating Revenue		 1,167 1,089 787 501 345 230 105 49
Total Cost of Revenue		 914 850 620 388 275 184 86 41
Operating Cost of Revenue		 914 850 620 388 275 184 86 41
Total Operating Expenses		 186 177 144 80 62 36 23 37
Selling, General & Admin Expense		 122 117 98 60 47 24 16 14
Marketing Expense		 64 59 46 20 15 12 7.29 4.26
Total Other Income / (Expense), net		 16 8.51 1.10 0.10 0.33 -18 -3.44 -2.91
Other Income / (Expense), net		 16 8.51 1.10 -0.37 0.21 -18 -2.94 -2.17
Income Tax Expense		 29 8.65 -5.92 -33 -38 0.01 -1.78 -0.00
Basic Earnings per Share		 $0.59 $0.65 $0.33 $0.74 $0.54 ($0.41) $0.04 ($2.37)
Weighted Average Basic Shares Outstanding		 91.48M 95.02M 92.20M 89.11M 85.72M 20.74M 5.54M 5.68M
Diluted Earnings per Share		 $0.57 $0.62 $0.30 $0.66 $0.47 ($0.41) $0.04 ($2.37)
Weighted Average Diluted Shares Outstanding		 95.45M 100.67M 99.96M 100.36M 99.06M 20.74M 5.54M 5.68M
Weighted Average Basic & Diluted Shares Outstanding		 85.41M 96.50M 93.38M 91.23M 87.22M 20.74M 5.54M 5.68M

Quarterly Income Statements for Progyny

This table shows Progyny's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 11 10 16 17 13 16 15 18 3.41 13
Consolidated Net Income / (Loss)		 11 10 16 17 13 16 15 18 3.41 13
Net Income / (Loss) Continuing Operations		 11 10 16 17 13 16 15 18 3.41 13
Total Pre-Tax Income 		18 18 25 23 16 21 17 16 4.14 12
Total Operating Income		 16 12 21 19 14 18 15 15 3.31 11
Total Gross Profit		 63 59 68 62 57 63 61 59 44 46
Total Revenue		 298 287 304 278 270 281 279 258 214 205
Operating Revenue		 298 287 304 278 270 281 279 258 214 205
Total Cost of Revenue		 235 227 236 216 213 218 219 200 170 159
Operating Cost of Revenue		 235 227 236 216 213 218 219 200 170 159
Total Operating Expenses		 48 47 48 44 43 44 45 44 41 35
Selling, General & Admin Expense		 32 30 31 28 28 30 30 29 28 24
Marketing Expense		 16 16 16 15 15 15 15 14 13 11
Total Other Income / (Expense), net		 1.87 5.50 4.38 3.99 2.46 2.74 1.98 1.32 0.84 0.28
Other Income / (Expense), net		 3.32 5.50 3.56 3.36 3.99 2.74 1.28 0.50 1.09 0.08
Income Tax Expense		 7.13 7.54 8.58 5.62 2.79 5.03 2.18 -1.35 0.73 -1.67
Basic Earnings per Share		 $0.11 $0.12 $0.18 $0.18 $0.13 $0.17 $0.16 $0.19 $0.04 $0.14
Weighted Average Basic Shares Outstanding		 91.48M 90.07M 93.87M 96.48M 95.02M 95.50M 94.74M 93.83M 92.20M 92.32M
Diluted Earnings per Share		 $0.12 $0.11 $0.17 $0.17 $0.13 $0.16 $0.15 $0.18 $0.03 $0.13
Weighted Average Diluted Shares Outstanding		 95.45M 93.82M 97.84M 101.05M 100.67M 100.88M 100.62M 100.17M 99.96M 99.82M
Weighted Average Basic & Diluted Shares Outstanding		 85.41M 85.15M 90.28M 95.22M 96.50M 95.84M 95.41M 94.41M 93.38M 92.88M

Annual Cash Flow Statements for Progyny

This table details how cash moves in and out of Progyny's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Net Change in Cash & Equivalents		 65 -23 29 21 -10 80 -4.56 1.68
Net Cash From Operating Activities		 179 189 80 26 36 -1.53 2.27 -9.47
Net Cash From Continuing Operating Activities		 179 189 80 26 36 -1.53 2.27 -9.42
Net Income / (Loss) Continuing Operations		 54 62 30 66 46 -8.57 -5.12 -12
Consolidated Net Income / (Loss)		 54 62 30 66 46 -8.57 0.66 -12
Depreciation Expense		 3.18 2.28 1.60 1.30 1.91 2.13 1.88 1.56
Non-Cash Adjustments To Reconcile Net Income		 144 138 115 10 18 25 6.93 2.91
Changes in Operating Assets and Liabilities, net		 -22 -14 -66 -51 -31 -20 -1.42 -1.43
Net Cash From Investing Activities		 196 -201 -44 8.77 -40 -2.76 1.90 -0.61
Net Cash From Continuing Investing Activities		 196 -201 -44 8.77 -40 -2.96 -0.58 -0.61
Purchase of Property, Plant & Equipment		 -5.41 -3.64 -3.24 -2.13 -1.04 -2.96 -0.58 -0.61
Acquisitions		 -5.30 0.00 0.00 - - - - -
Purchase of Investments		 -170 -430 -163 -111 -104 - 0.00 -
Sale and/or Maturity of Investments		 377 233 123 122 65 - 0.00 -
Net Cash From Financing Activities		 -310 -11 -7.86 -14 -6.25 85 -8.74 12
Net Cash From Continuing Financing Activities		 -310 -11 -7.86 -14 -6.25 85 -8.74 12
Repurchase of Common Equity		 -300 0.00 0.00 - -0.89 -3.02 -1.21 0.00
Issuance of Common Equity		 1.30 1.28 1.15 1.35 1.24 81 0.00 0.00
Other Financing Activities, net		 -11 -12 -9.02 -15 -6.60 6.60 0.07 0.03
Effect of Exchange Rate Changes		 0.00 0.00 0.00 0.00 - - - -
Cash Income Taxes Paid		 40 6.18 0.13 0.10 0.00 - - -

Quarterly Cash Flow Statements for Progyny

This table details how cash moves in and out of Progyny's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 71 -3.48 -20 18 -61 -12 15 35 48 18
Net Cash From Operating Activities		 52 45 57 26 38 54 76 21 52 21
Net Cash From Continuing Operating Activities		 52 45 57 26 38 54 76 21 52 21
Net Income / (Loss) Continuing Operations		 11 10 16 17 13 16 15 18 3.41 13
Consolidated Net Income / (Loss)		 11 10 16 17 13 16 15 18 3.41 13
Depreciation Expense		 0.87 0.84 0.75 0.72 0.63 0.58 0.53 0.54 0.45 0.41
Non-Cash Adjustments To Reconcile Net Income		 34 43 34 32 29 38 35 36 33 27
Changes in Operating Assets and Liabilities, net		 3.19 -6.36 5.10 -24 -8.38 2.49 25 -33 14 -20
Net Cash From Investing Activities		 75 15 86 19 -93 -64 -59 16 -1.17 -1.88
Net Cash From Continuing Investing Activities		 75 15 86 19 -93 -64 -59 16 -1.17 -1.88
Purchase of Property, Plant & Equipment		 -1.75 -1.94 -0.87 -0.85 -0.55 -1.08 -0.76 -1.25 -0.72 -1.24
Sale and/or Maturity of Investments		 77 29 140 131 74 79 39 41 38 30
Net Cash From Financing Activities		 -56 -63 -163 -27 -5.03 -2.36 -1.84 -1.85 -2.79 -1.23
Net Cash From Continuing Financing Activities		 -56 -63 -163 -27 -5.03 -2.36 -1.84 -1.85 -2.79 -1.23
Repurchase of Common Equity		 -55 -61 -160 -24 - - - 0.00 - -
Issuance of Common Equity		 0.39 0.21 0.36 0.35 0.39 0.27 0.32 0.29 0.40 0.17
Other Financing Activities, net		 -1.61 -2.11 -3.19 -4.00 -5.42 -2.63 -2.16 -2.14 -3.19 -1.40
Cash Income Taxes Paid		 5.58 18 18 -0.36 3.86 1.62 0.72 -0.02 -0.01 0.09

Annual Balance Sheets for Progyny

This table presents Progyny's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Total Assets		 607 757 543 358 254 150 41
Total Current Assets		 473 640 434 259 190 132 25
Cash & Equivalents		 162 97 120 91 70 80 0.13
Short-Term Investments		 66 274 69 28 39 0.00 -
Accounts Receivable		 235 242 240 135 76 47 23
Prepaid Expenses		 9.44 27 4.49 4.56 5.26 5.00 0.89
Plant, Property, & Equipment, net		 12 10 8.37 5.03 3.40 3.08 0.78
Total Noncurrent Assets		 122 106 101 94 60 15 16
Goodwill		 16 12 12 12 12 12 12
Intangible Assets		 1.30 0.00 0.10 0.60 1.21 2.38 3.86
Noncurrent Deferred & Refundable Income Taxes		 85 73 78 71 38 0.00 -
Other Noncurrent Operating Assets		 20 21 11 11 9.24 0.65 0.27
Total Liabilities & Shareholders' Equity		 607 757 543 358 254 150 41
Total Liabilities		 185 203 166 106 87 36 30
Total Current Liabilities		 169 186 160 99 78 36 30
Accounts Payable		 95 125 109 61 44 19 16
Accrued Expenses		 74 61 50 37 34 17 9.78
Total Noncurrent Liabilities		 16 17 6.48 7.42 9.19 0.00 0.00
Other Noncurrent Operating Liabilities		 16 17 6.48 7.42 9.19 0.00 -
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 422 553 377 252 167 114 -95
Total Preferred & Common Equity		 422 553 377 252 167 114 -95
Total Common Equity		 422 553 377 252 167 114 -95
Common Stock		 582 462 350 255 236 229 11
Retained Earnings		 144 90 28 -2.42 -68 -113 -105
Treasury Stock		 -304 -1.01 - - - - -
Accumulated Other Comprehensive Income / (Loss)		 0.04 2.82 0.50 -0.09 0.00 0.00 -

Quarterly Balance Sheets for Progyny

This table presents Progyny's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets		 660 699 794 727 682 650 510
Total Current Assets		 546 582 682 611 561 527 402
Cash & Equivalents		 91 95 115 158 171 155 73
Short-Term Investments		 144 167 257 177 112 53 68
Accounts Receivable		 281 294 297 269 265 313 258
Prepaid Expenses		 30 26 12 6.95 14 5.95 2.84
Plant, Property, & Equipment, net		 12 11 10 9.72 9.50 8.88 7.20
Total Noncurrent Assets		 102 106 103 106 111 114 101
Goodwill		 16 16 12 12 12 12 12
Intangible Assets		 1.45 1.48 - 0.00 0.00 0.00 0.22
Noncurrent Deferred & Refundable Income Taxes		 64 68 70 72 77 79 78
Other Noncurrent Operating Assets		 21 21 20 22 22 23 11
Total Liabilities & Shareholders' Equity		 660 699 794 727 682 650 510
Total Liabilities		 225 242 223 211 212 225 164
Total Current Liabilities		 208 225 206 193 194 207 157
Accounts Payable		 130 152 130 132 130 146 104
Accrued Expenses		 78 74 76 61 64 61 53
Total Noncurrent Liabilities		 17 17 17 18 18 18 6.72
Other Noncurrent Operating Liabilities		 17 17 17 18 18 18 6.72
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 435 456 572 515 469 424 347
Total Preferred & Common Equity		 435 456 572 515 469 424 347
Total Common Equity		 435 456 572 515 469 424 347
Common Stock		 552 520 489 438 409 379 323
Retained Earnings		 134 123 107 77 61 46 25
Treasury Stock		 -251 - -27 - - - -
Accumulated Other Comprehensive Income / (Loss)		 0.33 2.03 2.75 1.85 1.08 0.72 0.21

Annual Metrics And Ratios for Progyny

This table displays calculated financial ratios and metrics derived from Progyny's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Growth Metrics		 - - - - - - - -
Revenue Growth		 7.22% 38.34% 57.19% 45.17% 50.15% 117.92% 116.94% 0.00%
EBITDA Growth		 18.37% 180.21% -21.74% 218.00% 264.37% -41.06% 61.14% 0.00%
EBIT Growth		 17.70% 189.23% -23.56% 273.62% 200.69% -32.88% 51.45% 0.00%
NOPAT Growth		 -19.28% 88.23% -55.79% 46.75% 559.70% 380.33% 68.63% 0.00%
Net Income Growth		 -12.41% 104.35% -53.84% 41.56% 642.18% -1,396.37% 105.31% 0.00%
EPS Growth		 -8.06% 106.67% -54.55% 40.43% 214.63% -1,125.00% 101.69% 0.00%
Operating Cash Flow Growth		 -5.14% 134.86% 208.77% -28.08% 2,460.04% -167.52% 123.98% 0.00%
Free Cash Flow Firm Growth		 -46.10% 327.99% -186.20% -143.86% 230.25% -19.33% 0.00% 0.00%
Invested Capital Growth		 6.45% -2.84% 41.74% 129.68% 70.11% 206.74% 0.00% 0.00%
Revenue Q/Q Growth		 2.50% 5.38% 12.39% 5.76% 11.36% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 5.95% 24.58% 23.80% -5.19% 96.62% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 5.88% 25.16% 24.92% -4.98% 156.15% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 -3.89% 18.97% -30.83% -26.25% 443.40% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 -5.13% 19.36% -27.77% -26.73% 1,455.37% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 -1.72% 19.23% -28.57% -26.67% -38.16% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 8.81% -6.84% 113.29% 9.59% 49.74% -119.05% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 21.74% -16.68% 51.48% -745.81% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 -2.53% 1.39% -8.84% 20.58% 158.42% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - -
Gross Margin		 21.71% 21.94% 21.26% 22.40% 20.32% 19.81% 18.44% 15.23%
EBITDA Margin		 7.40% 6.70% 3.31% 6.65% 3.03% -2.77% -4.28% -23.91%
Operating Margin		 5.78% 5.71% 2.97% 6.46% 2.42% 4.21% -3.28% -22.65%
EBIT Margin		 7.13% 6.49% 3.11% 6.39% 2.48% -3.70% -6.07% -27.11%
Profit (Net Income) Margin		 4.66% 5.70% 3.86% 13.14% 13.47% -3.73% 0.63% -25.63%
Tax Burden Percent		 65.31% 87.76% 124.21% 202.77% 535.30% 100.14% -9.59% 99.94%
Interest Burden Percent		 100.00% 100.00% 100.00% 101.44% 101.41% 100.68% 107.77% 94.58%
Effective Tax Rate		 34.69% 12.24% -24.21% -102.77% -435.30% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 23.40% 29.50% 18.12% 69.01% 97.64% 30.15% -43.74% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 19.97% 26.83% 17.23% 68.84% 95.77% 68.29% -8,361.04% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 -12.26% -16.16% -8.46% -37.60% -64.60% -43.82% 55.63% 0.00%
Return on Equity (ROE)		 11.14% 13.34% 9.66% 31.41% 33.04% -13.67% 11.89% 0.00%
Cash Return on Invested Capital (CROIC)		 17.15% 32.38% -16.42% -9.66% 45.73% -71.51% -243.74% 0.00%
Operating Return on Assets (OROA)		 12.20% 10.88% 5.43% 10.45% 4.23% -8.86% -15.48% 0.00%
Return on Assets (ROA)		 7.97% 9.55% 6.74% 21.49% 22.98% -8.94% 1.60% 0.00%
Return on Common Equity (ROCE)		 11.14% 13.34% 9.66% 31.41% 33.04% -2.09% -101.65% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 12.87% 11.21% 8.05% 26.12% 27.83% -7.50% -0.69% 0.00%
Net Operating Profit after Tax (NOPAT)		 44 55 29 66 45 6.77 -2.42 -7.70
NOPAT Margin		 3.77% 5.01% 3.68% 13.10% 12.96% 2.95% -2.29% -15.86%
Net Nonoperating Expense Percent (NNEP)		 3.43% 2.66% 0.89% 0.17% 1.87% -38.14% 8,317.30% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 10.44% 9.86% 7.69% - - - - -
Cost of Revenue to Revenue		 78.29% 78.06% 78.74% 77.60% 79.68% 80.19% 81.56% 84.77%
SG&A Expenses to Revenue		 10.45% 10.76% 12.50% 11.91% 13.54% 10.42% 14.80% 29.12%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 15.93% 16.22% 18.30% 15.94% 17.89% 15.60% 21.71% 75.77%
Earnings before Interest and Taxes (EBIT)		 83 71 24 32 8.56 -8.50 -6.40 -13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 86 73 26 33 10 -6.37 -4.51 -12
Valuation Ratios		 - - - - - - - -
Price to Book Value (P/BV)		 3.48 6.44 7.68 18.08 22.00 20.19 0.00 0.00
Price to Tangible Book Value (P/TBV)		 3.62 6.58 7.93 19.02 23.87 23.07 0.00 0.00
Price to Revenue (P/Rev)		 1.26 3.27 3.68 9.10 10.65 10.04 1.23 2.68
Price to Earnings (P/E)		 27.03 57.44 95.31 69.23 79.05 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 3.70% 1.74% 1.05% 1.44% 1.27% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 6.39 17.51 14.41 33.49 61.81 65.71 21.39 0.00
Enterprise Value to Revenue (EV/Rev)		 1.06 2.93 3.44 8.86 10.33 9.69 2.24 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 14.37 43.74 103.83 133.25 340.51 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 14.91 45.16 110.63 138.67 416.35 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 28.17 58.49 93.27 67.61 79.73 328.72 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 6.93 16.91 33.63 170.29 98.42 0.00 104.03 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 38.44 53.29 0.00 0.00 170.25 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.61 -0.60 -0.49 -0.55 -0.67 -0.64 -0.01 0.00
Leverage Ratio		 1.40 1.40 1.43 1.46 1.44 1.53 3.72 0.00
Compound Leverage Factor		 1.40 1.40 1.43 1.48 1.46 1.54 4.00 0.00
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.22% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.22% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 933.95% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% -836.18% 0.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 -0.06 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 -0.03 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 -0.10 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 -0.05 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 8.07 13.16 12.73 27.93 26.96 39.33 0.91 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 84.72% 955.20% 0.00%
Liquidity Ratios		 - - - - - - - -
Current Ratio		 2.80 3.44 2.72 2.62 2.45 3.66 0.81 0.00
Quick Ratio		 2.75 3.30 2.69 2.57 2.38 3.52 0.78 0.00
Cash Flow Metrics		 - - - - - - - -
Free Cash Flow to Firm (FCFF)		 32 60 -26 -9.18 21 -16 -13 0.00
Operating Cash Flow to CapEx		 3,313.69% 5,181.50% 2,480.56% 1,222.97% 3,491.13% -51.89% 392.40% -1,548.04%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -277.02 -27.09 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -26.45 4.57 -12.80
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -77.41 3.41 -13.63
Efficiency Ratios		 - - - - - - - -
Asset Turnover		 1.71 1.68 1.75 1.64 1.71 2.40 2.55 0.00
Accounts Receivable Turnover		 4.89 4.52 4.20 4.76 5.62 6.53 4.52 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 103.31 117.15 117.47 118.81 106.39 119.04 135.82 0.00
Accounts Payable Turnover		 8.29 7.24 7.26 7.41 8.74 10.53 5.52 0.00
Days Sales Outstanding (DSO)		 74.61 80.80 86.88 76.64 64.95 55.93 80.77 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 44.04 50.41 50.28 49.29 41.77 34.65 66.14 0.00
Cash Conversion Cycle (CCC)		 30.57 30.39 36.61 27.35 23.17 21.28 14.63 0.00
Capital & Investment Metrics		 - - - - - - - -
Invested Capital		 194 182 188 132 58 34 11 0.00
Invested Capital Turnover		 6.20 5.88 4.92 5.27 7.53 10.22 19.08 0.00
Increase / (Decrease) in Invested Capital		 12 -5.33 55 75 24 23 11 0.00
Enterprise Value (EV)		 1,241 3,192 2,704 4,434 3,563 2,227 236 0.00
Market Capitalization		 1,469 3,563 2,893 4,553 3,672 2,307 130 130
Book Value per Share		 $4.96 $5.77 $4.06 $2.78 $1.93 $1.36 ($17.17) $0.00
Tangible Book Value per Share		 $4.76 $5.65 $3.93 $2.65 $1.78 $1.19 ($20.01) $0.00
Total Capital		 422 553 377 252 167 114 11 0.00
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.25 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -228 -371 -189 -119 -109 -80 0.13 0.00
Capital Expenditures (CapEx)		 5.41 3.64 3.24 2.13 1.04 2.96 0.58 0.61
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 76 83 85 40 3.14 16 -5.54 0.00
Debt-free Net Working Capital (DFNWC)		 304 454 274 160 112 96 -5.41 0.00
Net Working Capital (NWC)		 304 454 274 160 112 96 -5.67 0.00
Net Nonoperating Expense (NNE)		 -10 -7.47 -1.37 -0.19 -1.77 15 -3.08 4.75
Net Nonoperating Obligations (NNO)		 -228 -371 -189 -119 -109 -80 -0.07 0.00
Total Depreciation and Amortization (D&A)		 3.18 2.28 1.60 1.30 1.91 2.13 1.88 1.56
Debt-free, Cash-free Net Working Capital to Revenue		 6.52% 7.66% 10.80% 8.05% 0.91% 6.92% -5.26% 0.00%
Debt-free Net Working Capital to Revenue		 26.05% 41.75% 34.86% 31.90% 32.60% 41.92% -5.13% 0.00%
Net Working Capital to Revenue		 26.05% 41.75% 34.86% 31.90% 32.60% 41.92% -5.37% 0.00%
Earnings Adjustments		 - - - - - - - -
Adjusted Basic Earnings per Share		 $0.59 $0.65 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 91.48M 95.02M 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Diluted Earnings per Share		 $0.57 $0.62 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 95.45M 100.67M 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 85.41M 96.50M 0.00 0.00 0.00 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 44 55 16 23 5.84 6.77 -2.42 -7.70
Normalized NOPAT Margin		 3.77% 5.01% 2.08% 4.52% 1.69% 2.95% -2.29% -15.86%
Pre Tax Income Margin		 7.13% 6.49% 3.11% 6.48% 2.52% -3.73% -6.54% -25.64%
Debt Service Ratios		 - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -146.53 -12.87 -17.80
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 116.79 -4.86 -10.41
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -197.50 -14.03 -18.63
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 65.83 -6.03 -11.24
Payout Ratios		 - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 552.63% 0.00% 0.00% 0.00% 1.92% -35.24% 182.30% 0.00%

Quarterly Metrics And Ratios for Progyny

This table displays calculated financial ratios and metrics derived from Progyny's official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 10.55% 2.04% 8.85% 7.62% 25.95% 36.77% 43.27% 50.04% 68.03% 67.95%
EBITDA Growth		 8.41% -12.60% 47.19% 40.80% 280.58% 83.19% 83.67% 7,542.86% 3,033.94% 27.08%
EBIT Growth		 7.40% -14.18% 47.32% 41.10% 304.78% 84.63% 85.73% 10,170.78% 1,013.72% 26.35%
NOPAT Growth		 -17.62% -47.68% 2.60% -14.45% 320.12% 7.21% 52.34% 40,122.48% 2,167.48% -22.84%
Net Income Growth		 -21.81% -34.45% 9.97% -4.41% 295.25% 20.34% 70.97% 255.62% -77.40% -21.34%
EPS Growth		 -7.69% -31.25% 13.33% -5.56% 333.33% 23.08% 66.67% 260.00% -80.00% -23.53%
Operating Cash Flow Growth		 38.52% -17.84% -25.41% 22.76% -26.90% 159.32% 294.95% 286.12% 484.42% -13.53%
Free Cash Flow Firm Growth		 -114.02% -130.34% -55.66% 216.42% 131.89% 147.90% 121.47% 72.66% 29.84% -17.49%
Invested Capital Growth		 6.45% 10.74% 3.74% -7.73% -2.84% -12.64% -0.87% 24.47% 41.74% 87.48%
Revenue Q/Q Growth		 4.12% -5.74% 9.35% 3.01% -3.90% 0.54% 8.12% 20.56% 4.36% 5.32%
EBITDA Q/Q Growth		 6.25% -24.82% 10.65% 39.90% -14.35% 26.62% 5.84% 298.56% -58.77% 26.95%
EBIT Q/Q Growth		 6.37% -25.93% 10.82% 41.00% -15.01% 27.16% 6.14% 333.09% -61.23% 27.91%
NOPAT Q/Q Growth		 30.28% -46.87% -2.14% 21.62% -17.26% 4.19% -18.40% 497.22% -78.89% 48.05%
Net Income Q/Q Growth		 1.07% -36.79% -2.44% 25.45% -15.27% 6.05% -15.20% 418.72% -74.20% 50.67%
EPS Q/Q Growth		 9.09% -35.29% 0.00% 30.77% -18.75% 6.67% -16.67% 500.00% -76.92% 44.44%
Operating Cash Flow Q/Q Growth		 17.18% -21.48% 120.32% -31.67% -30.50% -28.72% 262.64% -59.31% 146.56% 8.56%
Free Cash Flow Firm Q/Q Growth		 80.56% -283.04% -78.45% 82.86% -57.94% 167.47% 156.59% 49.91% 36.83% -19.91%
Invested Capital Q/Q Growth		 -2.53% 2.66% -2.89% 9.56% 1.39% -3.83% -13.63% 15.37% -8.84% 9.13%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 21.26% 20.67% 22.45% 22.44% 21.08% 22.29% 21.71% 22.69% 20.76% 22.40%
EBITDA Margin		 6.69% 6.56% 8.22% 8.13% 6.83% 7.66% 6.08% 6.21% 2.26% 5.72%
Operating Margin		 5.29% 4.35% 6.80% 6.66% 5.11% 6.48% 5.44% 5.81% 1.54% 5.48%
EBIT Margin		 6.40% 6.27% 7.98% 7.87% 6.59% 7.45% 5.89% 6.00% 2.05% 5.52%
Profit (Net Income) Margin		 3.53% 3.64% 5.42% 6.08% 4.99% 5.66% 5.37% 6.84% 1.59% 6.43%
Tax Burden Percent		 59.64% 58.02% 65.76% 75.05% 82.83% 75.95% 87.32% 108.25% 82.30% 114.49%
Interest Burden Percent		 92.42% 100.00% 103.36% 102.89% 91.41% 100.00% 104.29% 105.30% 94.22% 101.78%
Effective Tax Rate		 40.36% 41.98% 34.24% 24.95% 17.17% 24.05% 12.68% -8.25% 17.70% -14.49%
Return on Invested Capital (ROIC)		 19.57% 15.15% 26.61% 26.62% 24.92% 26.34% 24.19% 28.12% 6.24% 27.83%
ROIC Less NNEP Spread (ROIC-NNEP)		 19.19% 14.04% 25.55% 25.59% 24.19% 25.47% 23.34% 27.21% 5.80% 27.58%
Return on Net Nonoperating Assets (RNNOA)		 -11.79% -8.44% -15.03% -14.89% -14.57% -14.08% -12.11% -12.12% -2.85% -12.33%
Return on Equity (ROE)		 7.78% 6.72% 11.57% 11.73% 10.35% 12.27% 12.09% 16.00% 3.40% 15.50%
Cash Return on Invested Capital (CROIC)		 17.15% 14.00% 23.99% 33.19% 32.38% 37.28% 24.75% -1.10% -16.42% -34.31%
Operating Return on Assets (OROA)		 10.96% 10.29% 13.09% 12.08% 11.04% 12.45% 9.86% 9.84% 3.58% 9.12%
Return on Assets (ROA)		 6.04% 5.97% 8.90% 9.33% 8.36% 9.45% 8.98% 11.21% 2.78% 10.63%
Return on Common Equity (ROCE)		 7.78% 6.72% 11.57% 11.73% 10.35% 12.27% 12.09% 16.00% 3.40% 15.50%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 13.17% 13.76% 10.72% 0.00% 10.08% 10.50% 10.15% 0.00% 12.12%
Net Operating Profit after Tax (NOPAT)		 9.42 7.23 14 14 11 14 13 16 2.72 13
NOPAT Margin		 3.16% 2.52% 4.47% 5.00% 4.23% 4.92% 4.75% 6.29% 1.27% 6.27%
Net Nonoperating Expense Percent (NNEP)		 0.37% 1.12% 1.06% 1.03% 0.73% 0.87% 0.86% 0.91% 0.45% 0.25%
Return On Investment Capital (ROIC_SIMPLE)		 2.23% - - - 2.07% - - - 0.72% -
Cost of Revenue to Revenue		 78.74% 79.33% 77.55% 77.56% 78.92% 77.71% 78.29% 77.31% 79.24% 77.60%
SG&A Expenses to Revenue		 10.73% 10.58% 10.25% 10.22% 10.44% 10.51% 10.76% 11.36% 13.16% 11.48%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 15.97% 16.32% 15.65% 15.78% 15.96% 15.82% 16.27% 16.88% 19.22% 16.92%
Earnings before Interest and Taxes (EBIT)		 19 18 24 22 18 21 16 16 4.40 11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 20 19 25 23 18 22 17 16 4.84 12
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 3.48 3.48 5.97 6.44 6.44 6.30 7.91 7.07 7.68 9.84
Price to Tangible Book Value (P/TBV)		 3.62 3.62 6.20 6.58 6.58 6.45 8.12 7.27 7.93 10.19
Price to Revenue (P/Rev)		 1.26 1.33 2.40 3.32 3.27 3.14 3.88 3.44 3.68 4.87
Price to Earnings (P/E)		 27.03 26.42 43.41 60.10 57.44 62.45 75.35 69.65 95.31 81.19
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 3.70% 3.79% 2.30% 1.66% 1.74% 1.60% 1.33% 1.44% 1.05% 1.23%
Enterprise Value to Invested Capital (EV/IC)		 6.39 6.41 12.69 16.57 17.51 16.18 18.35 12.89 14.41 15.89
Enterprise Value to Revenue (EV/Rev)		 1.06 1.12 2.17 2.99 2.93 2.82 3.58 3.20 3.44 4.67
Enterprise Value to EBITDA (EV/EBITDA)		 14.37 15.67 29.23 43.42 43.74 49.68 70.31 67.97 103.83 155.52
Enterprise Value to EBIT (EV/EBIT)		 14.91 16.25 30.19 44.87 45.16 51.52 73.18 71.05 110.63 167.21
Enterprise Value to NOPAT (EV/NOPAT)		 28.17 27.87 46.72 63.22 58.49 63.44 76.50 69.04 93.27 78.05
Enterprise Value to Operating Cash Flow (EV/OCF)		 6.93 7.76 14.13 17.10 16.91 14.36 20.26 24.79 33.63 86.79
Enterprise Value to Free Cash Flow (EV/FCFF)		 38.44 48.16 53.87 47.90 53.29 40.48 73.81 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.61 -0.60 -0.59 -0.58 -0.60 -0.55 -0.52 -0.45 -0.49 -0.45
Leverage Ratio		 1.40 1.46 1.49 1.45 1.40 1.43 1.47 1.51 1.43 1.48
Compound Leverage Factor		 1.29 1.46 1.54 1.49 1.28 1.43 1.53 1.59 1.35 1.51
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 7.72 6.75 9.34 12.31 12.93 11.58 12.77 10.10 12.61 14.60
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 2.80 2.62 2.58 3.31 3.44 3.16 2.89 2.55 2.72 2.56
Quick Ratio		 2.75 2.48 2.47 3.25 3.30 3.12 2.82 2.52 2.69 2.54
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -2.35 -12 6.60 31 17 40 15 -26 -53 -83
Operating Cash Flow to CapEx		 2,979.10% 2,296.96% 6,546.65% 3,027.29% 6,809.95% 5,012.21% 10,014.76% 1,675.54% 7,145.22% 1,685.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 1.71 1.64 1.64 1.54 1.68 1.67 1.67 1.64 1.75 1.65
Accounts Receivable Turnover		 4.89 4.14 4.06 3.63 4.52 3.92 3.87 3.41 4.20 3.56
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 103.31 105.22 112.55 115.95 117.15 122.12 121.40 118.71 117.47 117.64
Accounts Payable Turnover		 8.29 6.80 6.26 6.28 7.24 6.83 6.71 5.91 7.26 6.92
Days Sales Outstanding (DSO)		 74.61 88.06 90.00 100.52 80.80 93.07 94.32 106.89 86.88 102.50
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 44.04 53.71 58.28 58.14 50.41 53.44 54.39 61.80 50.28 52.74
Cash Conversion Cycle (CCC)		 30.57 34.35 31.72 42.38 30.39 39.63 39.93 45.09 36.61 49.75
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 194 199 194 200 182 180 187 217 188 206
Invested Capital Turnover		 6.20 6.01 5.95 5.32 5.88 5.36 5.10 4.47 4.92 4.44
Increase / (Decrease) in Invested Capital		 12 19 7.00 -17 -5.33 -26 -1.64 43 55 96
Enterprise Value (EV)		 1,241 1,277 2,462 3,310 3,192 2,910 3,431 2,791 2,704 3,272
Market Capitalization		 1,469 1,513 2,724 3,681 3,563 3,246 3,714 2,999 2,893 3,413
Book Value per Share		 $4.96 $4.82 $4.79 $5.92 $5.77 $5.40 $4.97 $4.55 $4.06 $3.77
Tangible Book Value per Share		 $4.76 $4.63 $4.61 $5.80 $5.65 $5.28 $4.85 $4.42 $3.93 $3.64
Total Capital		 422 435 456 572 553 515 469 424 377 347
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -228 -236 -262 -372 -371 -336 -282 -208 -189 -141
Capital Expenditures (CapEx)		 1.75 1.94 0.87 0.85 0.55 1.08 0.76 1.25 0.72 1.24
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 76 102 95 104 83 82 85 112 85 104
Debt-free Net Working Capital (DFNWC)		 304 338 357 476 454 418 367 320 274 245
Net Working Capital (NWC)		 304 338 357 476 454 418 367 320 274 245
Net Nonoperating Expense (NNE)		 -1.12 -3.19 -2.88 -3.00 -2.04 -2.08 -1.73 -1.43 -0.69 -0.33
Net Nonoperating Obligations (NNO)		 -228 -236 -262 -372 -371 -336 -282 -208 -189 -141
Total Depreciation and Amortization (D&A)		 0.87 0.84 0.75 0.72 0.63 0.58 0.53 0.54 0.45 0.41
Debt-free, Cash-free Net Working Capital to Revenue		 6.52% 8.97% 8.36% 9.36% 7.66% 7.97% 8.85% 12.87% 10.80% 14.85%
Debt-free Net Working Capital to Revenue		 26.05% 29.67% 31.50% 42.91% 41.75% 40.45% 38.35% 36.68% 34.86% 34.99%
Net Working Capital to Revenue		 26.05% 29.67% 31.50% 42.91% 41.75% 40.45% 38.35% 36.68% 34.86% 34.99%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.11 $0.12 $0.18 $0.18 $0.13 $0.17 $160.00 $0.19 $0.04 $0.14
Adjusted Weighted Average Basic Shares Outstanding		 91.48M 90.07M 93.87M 96.48M 95.02M 95.50M 94.74K 93.83M 92.20M 92.32M
Adjusted Diluted Earnings per Share		 $0.12 $0.11 $0.17 $0.17 $0.13 $0.16 $150.00 $0.18 $0.03 $0.13
Adjusted Weighted Average Diluted Shares Outstanding		 95.45M 93.82M 97.84M 101.05M 100.67M 100.88M 100.62K 100.17M 99.96M 99.82M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 85.41M 85.15M 90.28M 95.22M 96.50M 95.84M 95.41M 94.41M 93.38M 92.88M
Normalized Net Operating Profit after Tax (NOPAT)		 9.42 7.23 14 14 11 14 13 11 2.72 7.88
Normalized NOPAT Margin		 3.16% 2.52% 4.47% 5.00% 4.23% 4.92% 4.75% 4.07% 1.27% 3.84%
Pre Tax Income Margin		 5.92% 6.27% 8.24% 8.10% 6.02% 7.45% 6.14% 6.32% 1.93% 5.62%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 552.63% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Progyny's Financials

When does Progyny's financial year end?

According to the most recent income statement we have on file, Progyny's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Progyny's net income changed over the last 7 years?

Progyny's net income appears to be on an upward trend, with a most recent value of $54.34 million in 2024, falling from -$12.45 million in 2017. The previous period was $62.04 million in 2023. See where experts think Progyny is headed by visiting Progyny's forecast page.

What is Progyny's operating income?
Progyny's total operating income in 2024 was $67.46 million, based on the following breakdown:
  • Total Gross Profit: $253.36 million
  • Total Operating Expenses: $185.91 million
How has Progyny revenue changed over the last 7 years?

Over the last 7 years, Progyny's total revenue changed from $48.58 million in 2017 to $1.17 billion in 2024, a change of 2,302.5%.

How much debt does Progyny have?

Progyny's total liabilities were at $185.04 million at the end of 2024, a 8.9% decrease from 2023, and a 512.7% increase since 2018.

How much cash does Progyny have?

In the past 6 years, Progyny's cash and equivalents has ranged from $127 thousand in 2018 to $162.31 million in 2024, and is currently $162.31 million as of their latest financial filing in 2024.

How has Progyny's book value per share changed over the last 7 years?

Over the last 7 years, Progyny's book value per share changed from 0.00 in 2017 to 4.96 in 2024, a change of 495.7%.


Related Companies

This page (NASDAQ:PGNY) was last updated on 6/1/2025 by MarketBeat.com Staff
From Our Partners
Trump Just Gave the Green Light to Rewrite Social Security?
In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...
Altimetry | Sponsored
Banks aren’t ready for this altcoin—are you?
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...
Crypto 101 Media | Sponsored
The “supermetal” that could power AI
While the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...
True Market Insiders | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...
Weiss Ratings | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
The Buffett Indicator is screaming, “sell stocks, buy gold”
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Crypto Is Pumping Again – Now Comes the Real Opportunity
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored